ANDA 74748, held by Egis Pharms. Captopril.
As of Nov 13, 2026, ANDA 74748 (Captopril), held by Egis Pharms, was first approved by FDA on May 29, 1997, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 29, 1997 | Original application | Approved | None posted |
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 11, 2000 | Supplement 1Labeling | Approved | None posted |
| May 29, 1997 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
